Physician profile
Benjamin E Mccurdy
NPI 1225254931
$2,151.17
in general payments reported to CMS, 2019-2025
33 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $488 · 2021: $429 · 2022: $217 · 2023: $111 · 2024: $133 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $478.32 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $269.60 | 2019-2023 | Ztlido |
| Boston Scientific Corporation | $265.12 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $167.75 | 2019-2020 | |
| Vertos Medical, INC. | $151.93 | 2019-2024 | Mild Device Kit |
| Nevro Corp. | $90.29 | 2020-2022 | |
| Horizon Therapeutics Plc | $90.16 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $68.58 | 2019-2020 | |
| Redhill Biopharma INC. | $47.24 | 2021-2022 | |
| Uswm, LLC | $44.51 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $41.51 | 2025 | |
| Biogen, INC. | $37.37 | 2021-2022 | |
| Mdd US Operations, LLC | $34.60 | 2019 | |
| Almatica Pharma LLC | $28.38 | 2021 | |
| Pfizer INC. | $27.24 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $25.93 | 2021 | |
| Amgen INC. | $25.20 | 2019 | |
| Abbott Laboratories | $24.22 | 2025 | Eterna |
| Saluda Medical Americas, INC. | $21.80 | 2024 | Evoke |
| Pacira Pharmaceuticals Incorporated | $19.67 | 2022 | |
| Spr Therapeutics, INC | $19.60 | 2025 | Sprint Pns System |
| Medtronic, INC. | $17.67 | 2023 | Intellis Adaptivestim |
| Kaleo, INC. | $17.19 | 2019 | |
| Avanos Medical | $16.41 | 2024 | Generator |
| Trevena, INC. | $16.00 | 2021 | |
| Biotronik Nro, INC. | $15.36 | 2025 | Prospera |
| Ibsa Pharma INC. | $15.17 | 2025 | Tirosint, Flector, Licart |
| Si-Bone, INC. | $14.65 | 2019 | |
| Shionogi INC | $14.06 | 2019 | |
| Radius Health, INC. | $12.08 | 2021 | |
| Stimwave Technologies Incorporated | $11.46 | 2022 | |
| Grt US Holding, INC. | $11.36 | 2021 | |
| Forte Bio-Pharma LLC | $10.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mccurdy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.